ImmunoPrecise Antibodies
(NASDAQ:IPA)
$1.25
-0.01[-0.79%]
At close: May 10
$1.25
0[0.00%]
After Hours: 6:14PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

ImmunoPrecise Antibodies Stock (NASDAQ:IPA), Quotes and News Summary

ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.

Open$1.250
Close$1.290
Volume / Avg.73.098K / 584.614K
Day Range1.240 - 1.360
52 Wk Range0.940 - 4.220
Market Cap$32.894M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
41
Short Interest
1.48%
Days to Cover3.53

Recent News

EXCLUSIVE: Immunoprecise Antibodies and InterSystems Integrate Vector Search With LENSai For AI-Driven Healthcare Applications
Immunoprecise Antibodies partners with InterSystems to integrate Vector Search of IRIS data platform with BioStrand's LENSai for AI-driven healthcare solutions. Revolutionize drug discovery with precise, scalable data analysis.
Vandana Singh
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Avi Kapoor
Sponsored
ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discovery
Even though we speak, listen, read and write every day, language is incredibly complex and ever-evolving. Context is critical to understanding. In the English language, there are a plethora of words that are spelled the same but have vastly different meanings depending on their context.
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.0
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
IPA

FAQ

Q

How do I buy ImmunoPrecise Antibodies (IPA) stock?

A

You can purchase shares of ImmunoPrecise Antibodies (NASDAQ: IPA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are ImmunoPrecise Antibodies's (IPA) competitors?

A

There are no as such competitors for ImmunoPrecise Antibodies.

Q

What is the target price for ImmunoPrecise Antibodies (IPA) stock?

A

The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by Benchmark on Friday, March 15, 2024. The analyst firm set a price target for 5.00 expecting IPA to rise to within 12 months (a possible 300.00% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for ImmunoPrecise Antibodies (IPA)?

A

The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $1.25 last updated May 10, 2024 at 6:14 PM EDT.

Q

Does ImmunoPrecise Antibodies (IPA) pay a dividend?

A

There are no upcoming dividends for ImmunoPrecise Antibodies.

Q

When is ImmunoPrecise Antibodies (NASDAQ:IPA) reporting earnings?

A

ImmunoPrecise Antibodies’s Q4 earnings are confirmed for Friday, July 5, 2024.

Q

Is ImmunoPrecise Antibodies (IPA) going to split?

A

There is no upcoming split for ImmunoPrecise Antibodies.

Q

What sector and industry does ImmunoPrecise Antibodies (IPA) operate in?

A

ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.